Osteochondroma is a non-cancerous overgrowth of cartilage and bone located near the pelvis, shoulder blades, knees, and legs. It is the most common type of skeletal neoplasm and is considered a developmental anomaly. It accounts for up to 35% of all benign bone tumours and 10-15% of all bone tumours in general.
Nowadays, advanced radiography methods such as CT (computed tomography) scan, ultrasound, and MRI are being used to detect and monitor the condition. Since most cases of osteochondroma are asymptomatic, treatment is usually not necessary. However, in the presence of symptoms such as pain, an excision or resection procedure may be performed to remove the excess cartilage.
Affordable and quality osteochondroma treatment is widely available in Southeast Asia, a region known for its excellence in the medical field and advanced diagnostic technologies. Many hospitals in countries such as Malaysia, Singapore, and Thailand have world-class facilities, advanced equipment, and excellent medical staff. These countries offer affordable but high-quality medical care that meets Western standards.
Southeast Asia is home to many hospitals accredited by the Joint Commission International (JCI) in recognition of the high quality of medical care they provide. To be accredited by JCI, a hospital’s facilities and technologies must pass extensive quality evaluations. After accreditation, JCI continues to give guidance to these hospitals to ensure that they adhere to the evolving standards of the institution and to encourage them to continue to innovate and improve their services.
Some hospitals in Malaysia that have received accreditation for their medical programmes are Gleneagles Kuala Lumpur, Institut Jantung Negara, and Subang Jaya Medical Center. These hospitals offer innovative imaging technologies that are used for diagnosing conditions like osteochondroma.